Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Schering AG grants Bausch & Lomb license to SEGRA for ophthalmic use

Sep. 20, 2006

Santen patents novel strategy for allergic conjunctivitis

Sep. 20, 2006

Phase IIa study of microplasmin in vitrectomy completes treatment

Sep. 19, 2006

Preclinical testing for Advanced Refractive Technologies' novel glaucoma treatment

Sep. 15, 2006

Bevasiranib shows biological effect in wet AMD

Sep. 14, 2006

Oxigene updates CA4P ophthalmology strategy and trial status

Sep. 14, 2006

Israeli approval for phase II study of CF-101 in keratoconjunctivitis sicca

Sep. 8, 2006

New strategies for treatment of glaucoma reported in recent patents

Sep. 1, 2006

First European approval for Lucentis in Switzerland

Aug. 29, 2006

AzaSite NDA accepted for review

Aug. 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...